WebNov 24, 2024 · CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, November 24, 2024 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced financial results for the third quarter ended September 30, … WebDec 31, 2024 · Centogene N.V.’s shares began trading on Nasdaq Global Market, after pricing the initial public offering of 4,000,000 common shares at $14.00 per common share, raising net proceeds of approximately $46.6 million, after deducting underwriting discounts, commission and other expenses.
CENTOGENE Extends Strategic Partnership With Takeda …
WebApr 12, 2024 · Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced its… 7 Feb, … WebApr 11, 2024 · Any forward-looking statements contained in this press release speak only as of the date hereof, and CENTOGENE’s specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events, or otherwise. Contact: CENTOGENE Ben Legg Corporate Communications … don featherstone thanksgiving
CENTOGENE – The Rare Disease Company: centogene.com
WebApr 11, 2024 · Any forward-looking statements contained in this press release speak only as of the date hereof, and CENTOGENE’s specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events, or otherwise. Contact: CENTOGENE. Ben Legg Corporate Communications Web2 hours ago · Any forward-looking statements contained in this press release speak only as of the date hereof, and CENTOGENE’s specifically disclaims any obligation to update … WebFeb 7, 2024 · CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science … don featherstone turkey